"As we close the chapter on a volatile 2023 with a limited number of sizeable IPOs, we eagerly look to 2024 for economic conditions to stabilize and valuation expectations to continue to reset. A recent rally in the stock market, expectations of interest rate cuts by the Federal Reserve, as well as some recent high-profile confidential filings, lend optimism that we will see a more robust IPO market in 2024." Craig Clay, President of Global Capital Markets, DFIN
Congratulations to the 25 operating companies in Q4 who made their public debut via an IPO raising ~$2.8 billion and the 31 companies who made their public debut via a SPAC merger. Special congratulations to our clients:
- ABIVAX
- Banzai
- Birkenstock
- Captivision
- Cargo Therapeutics
- enGene
- flyExclusive
- Griid Infrastructure
- Lexeo Therapeutics
- MoneyHero
- Shimmick
- Spectaire
